期刊文献+

全球价值链视角下印度化药产业发展模式对我国的启示 被引量:5

Enlightenment from the experiences on development model of India pharmaceutical industry in the perspective of global value chain
原文传递
导出
摘要 以全球价值链理论为依据,分析了印度化药产业发展仿制药、出口驱动发展,承接研发外包的外向型模式;研究了印度本土跨国公司通过兼并重组、设立海外子公司,重视专利策略,加强新药研发,加大国际合作、加速国际认证,占据国际仿制药高端市场的国际化战略,阐述了印度医药产业全球价值链演进特征与升级路径;提出借鉴印度产业升级模式,制定国际化战略,嵌入全球价值链,支持龙头企业"走出去",提高我国医药产业国际竞争力的措施。 Based on the theory of global value chains,the export-oriented model of developing generic pharmaceutical industry,exporting driving development,and undertaking RD outsourcing of Indian pharmaceutical industry were analyzed.We investigated the international strategies carried out by the Indian multinational companies,such as,merger and reorganization,establishment of overseas subsidiaries,emphasis on patent strategy to improve drug RD.These have increased international cooperation,accelerated the international certification,and occupied the international generic high-end market.The evolution characteristics and upgrade path of global value chain of Indian pharmaceutical industry were elaborated.Finally,the effective measures how to improve the international competitiveness of China's pharmaceutical industry were advised,such as making reference of the industrial upgrading model in India,drafting an international strategy,embedding global value chain,and supporting leading enterprises' going out.
机构地区 中国药科大学
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第20期1847-1852,1878,共7页 Chinese Journal of New Drugs
关键词 全球价值链 印度 医药产业 发展模式 启示 global value chains India pharmaceutical industry development model enlightenment
  • 相关文献

参考文献5

二级参考文献23

  • 1孙国君.我国医药产业市场集中度浅析[J].中国药房,2004,15(10):588-590. 被引量:15
  • 2茅宁莹.印度医药企业新药研发经验启示[J].中国药房,2005,16(18):1369-1372. 被引量:9
  • 3张蕊.中印两国制药产业状况对比[J].上海医药,2006,27(3):106-108. 被引量:9
  • 4中国印度两国制药业对比分析及启示[EB/OL].(2003-12-15) [2009-1-20] . http: //scjss. mofcom, gov. cn/column/print, shtml? /ztxx/200312/20031200159785.
  • 5王静波.中印制药业竞争格局分析[EB/OL].(2007-08-21)[2009-1- 20]. http: / / www. biotech.org. cn/fruit/news-show.php? id=54635.
  • 6Prabuddha Ganguli. The Pharmaceutical Industry in India[J].Business Briefing Pharmatech. 2003, 37 (10): 828- 830.
  • 7Poorti Sativastava Marino. An Empirical Analysis of the Indian Pharmaceutical Industry[D].USA:Boston University , 2000: 16, 58, 62, 79, 88-88.
  • 8Government of India, Ministry of Law and Justice, Legislative Department. ThePatents (Amendment) Act, 2005, [S] . published in the Gazette of India Extraordinary, Part Ⅱ, Section 1, dated April 5, New Delhi, 2005.
  • 9The Drugs and Cosmetics Act. [EB/OL] . [2009-3-20] . http: //cdsco. nic. in/html/law, htm.
  • 10The Drugs and Cosmetics Rules.[EB/OL]. [2009-3-27]. http://cdsco. nic. in/htrnl/Drugs&CosmeticAct. pdf.

共引文献21

同被引文献59

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部